425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive's CFO reposting details on X.com.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication, a Form 425 filing, was reposted on X.com by Ben Pham, Chief Financial Officer of Strive, Inc., on September 24, 2025.
• The proposed transaction is subject to various conditions, including the approval of Semler Scientific's stockholders.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus, to register the Class A common stock to be issued in the transaction.
• The filing includes extensive cautionary statements regarding forward-looking statements and inherent risks and uncertainties associated with the merger.

Sentiment

Score: 5

Explanation: The filing is a procedural announcement of a proposed merger, balanced by extensive cautionary statements regarding forward-looking information and a comprehensive list of potential risks and uncertainties. It does not provide specific financial details to lean towards a strongly positive or negative sentiment.

Positives

• The proposed transaction is anticipated to yield strategic and financial benefits for the combined company.
• Management expects a positive impact on the combined company's future financial performance.
• The merger aims to successfully integrate the combined businesses.

Negatives

• The proposed transaction may be more difficult, time-consuming, or costly than initially expected.
• Integration of the two companies could present significant challenges.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will cause dilution for existing shareholders.
• There is a risk of adverse reactions from Strive's or Semler Scientific's customers, or changes to business or employee relationships, due to the announcement or completion of the merger.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific due to various circumstances.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all, potentially preventing the merger from closing.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company, impacting the transaction.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, partly due to changes in Bitcoin treasury strategies and risks associated with digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could negatively affect the combined company.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.

Future Outlook

The outlook and expectations for the proposed transaction include anticipated strategic and financial benefits, an expected positive impact on the combined company's future financial performance, and the successful integration of the businesses. The timing of the closing of the proposed transaction is also a key forward-looking aspect.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on X.com on September 24, 2025, in connection with the proposed business combination.

Industry Context

The filing's mention of 'Bitcoin treasury strategies' and 'risks associated with Bitcoin and other digital assets' indicates that the proposed business combination has implications for companies operating within or exposed to the digital asset and cryptocurrency sectors. This suggests a strategic move by the combined entity to leverage or manage digital asset holdings, a trend observed among a growing number of public companies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk to the transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed on July 17, 2025.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Customers and employees of both Strive and Semler Scientific may have adverse reactions or changes to their relationships due to the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus for the proposed transaction.
• Semler Scientific stockholders will be sent a definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Corporate Governance, Financial Reporting